IRUS Total

Adrenaline-mediated biased agonism at the B2 adrenoceptor in an in vivo model of takutsubo cardiomyopathy

File Description SizeFormat 
Paur-HE-2012-PhD-Thesis.pdf21.67 MBAdobe PDFView/Open
Title: Adrenaline-mediated biased agonism at the B2 adrenoceptor in an in vivo model of takutsubo cardiomyopathy
Authors: Paur, Helen Elizabeth
Item Type: Thesis or dissertation
Abstract: Stress (Takotsubo) cardiomyopathy is a severe form of acute heart failure (HF) with rapid onset, characterized by hypocontraction of the heart from the mid-left ventricle to apex. It is precipitated by extreme stress and plasma levels of the catecholamines adrenaline and noradrenaline are significantly elevated. This thesis describes the development of a new model of Takotsubo cardiomyopathy through rapid intravenous injection of a supraphysiological dose of adrenaline into anaesthetised male Sprague- Dawley (SD) rats and real-time imaging of the heart using either 2D-echocardiography or cardiac magnetic resonance (CMR). This in vivo rat model was used, in conjunction with in vitro IonOptix video-edge detection of cardiomyocyte contractility, to firstly demonstrate that this syndrome results from an adrenaline-induced trafficking-switch of the coupling of the pleiotropic β2-adrenceptor (AR) from Gs-adenylyl cyclase (AC)-cyclic adenosine monophosphate (cAMP) cardiostimulant to Gi-activated cardiodepressant pathways. Cardiomyocyte β2AR:β1AR population ratios, determined by radioligand binding, suggested that an apical-basal gradient in β2AR expression accounted for the in vivo apical hypokinesis. Certain β-blockers can act as biased agonists of a Gi-coupled isoform of the β2AR in animal and human cardiomyocytes via a pathway that involves p38 MAPK. Administration of the clinical β-blockers propranolol and carvedilol 15 minutes after adrenaline either enhanced or failed to reverse apical hypocontractility. In vitro analysis demonstrated that β2AR-Gi signalling involves p38 MAPK activation. However, pre-treatment with either the p38 MAPK inhibitor SB203580 or the β2AR blocker ICI-118,551 prior to adrenaline resulted in significant mortality, which suggested that the β2AR-Gs/Gi coupling switch is a cardioprotective strategy. Gi-protein is upregulated in chronic HF, while β1ARs are down-regulated. In contractility studies of chronically failing human/rat cardiomyocytes, β2AR-Gs responses were present with minimal active Gi-protein component. This suggested that while in acute HF β2AR-Gs positively inotropic responses are impaired and β1ARs are preserved, the opposite may be true in chronic HF.
Issue Date: 2012
Date Awarded: Apr-2012
URI: http://hdl.handle.net/10044/1/9617
DOI: https://doi.org/10.25560/9617
Supervisor: Lyon, Alexander
Gorelik, Julia
Harding, Sian
Department: National Heart and Lung Institute
Publisher: Imperial College London
Qualification Level: Doctoral
Qualification Name: Doctor of Philosophy (PhD)
Appears in Collections:National Heart and Lung Institute PhD theses

Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.

Creative Commons